dc.contributor.author
Ghadjar, Pirus
dc.contributor.author
Stritter, Wiebke
dc.contributor.author
Mackensen, Irina von
dc.contributor.author
Mehrhof, Felix
dc.contributor.author
Foucré, Clara
dc.contributor.author
Ehrhardt, Vincent H.
dc.contributor.author
Beck, Marcus
dc.contributor.author
Gebert, Pimrapat
dc.contributor.author
Kalinauskaite, Goda
dc.contributor.author
Luchte, Jacqueline S.
dc.contributor.author
Stromberger, Carmen
dc.contributor.author
Budach, Volker
dc.contributor.author
Eggert, Angelika
dc.contributor.author
Seifert, Georg
dc.date.accessioned
2023-03-07T16:19:10Z
dc.date.available
2023-03-07T16:19:10Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/38238
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-37956
dc.description.abstract
Background: Liver compresses are frequently used in integrative medicine as supportive therapy during cancer treatment in order to reduce fatigue. We performed a pilot study to test whether the external application of yarrow liver compresses impacts fatigue in patients with metastatic cancer undergoing radiation therapy.
Methods: A randomized prospective pilot trial was performed including patients with brain metastasis or bone metastasis of solid tumors. Patients underwent either palliative radiation therapy (RT) of the metastatic lesions (control group) over two weeks or the same RT with additional external application of yarrow liver compresses once daily during RT. The primary objective was improvement on the general fatigue subscale of the multidimensional fatigue inventory (MFI-20) at the end of treatment, where a mean difference of two points is considered clinically relevant. Secondary objectives included psychological distress, quality of life and qualitative analysis with self-established visual analogue scales (VAS). Mean differences in general fatigue at the end of treatment compared to baseline were analyzed using the ANCOVA test.
Results: From 09/2017 to 08/2019 a total of 39 patients were randomized. Due to drop outs 24 patients (12 per group) were available for analysis. Patients in the intervention group received a mean number of 10.5 (range, 7-14) applications of yarrow liver compresses. The mean improvement at the end of therapy on the general fatigue subscale of the MFI-20 was 2 points in favor of the intervention group (p = 0.13), and all other MFI-20 subscales showed at least a trend towards improvement in favor of the intervention group. Likewise, psychological distress and VAS data was improved, the latter reaching statistical significance for the symptoms fatigue, tension and lack of drive. Major toxicities were not observed.
Conclusions: External application of liver compresses appears to reduce fatigue within a clinical relevant range in patients with metastatic cancer undergoing radiation therapy. Trial registration: ISRCTN, ICTRP DRKS00012999
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
External application
en
dc.subject
Radiation therapy
en
dc.subject
Integrative medicine
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
External application of liver compresses to reduce fatigue in patients with metastatic cancer undergoing radiation therapy, a randomized clinical trial
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
76
dcterms.bibliographicCitation.doi
10.1186/s13014-021-01757-x
dcterms.bibliographicCitation.journaltitle
Radiation Oncology
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
16
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
33874968
dcterms.isPartOf.eissn
1748-717X